In this second of 2 podcasts episodes on the management of painful vaso-occlusive crises in patients with sickle cell disease, listen to Alison Towerman, RN, MSN, CPNP, and Michael R. DeBaun, MD, MPH, discuss  available treatment options for the prevention of painful vaso-occlusive events, and provide emergency department and outpatient setting recommendations on the proper use and indications for hydroxyurea, L-glutamine, and P-selecting blocking antibody crizanlizumab. This activity is available for 0.25 ANCC and 0.25 AAPA credits, with 0.25 credits applicable for pharmacology credit for NPs. To receive credit for this program, go to pce.is/sickle.Contributors:Michael R. DeBaun, MD, MPHDirectorVanderbilt-Meharry Center for Excellence in Sickle Cell DiseaseProfessorPediatrics and MedicineVice Chair for Clinical and Translational ResearchDepartment of PediatricsJ.C. Peterson Chair in PediatricsNashville, TennesseeMichael R. DeBaun, MD, MPH: consulting, speaker, and advisory board fees: Forma, GBT, Novartis, and Vertix.Alison Towerman, RN, MSN, CPNPPediatric Nurse PractitionerDepartment of Pediatrics, Division of Hematology/OncologyWashington University School of Medicine in St. LouisSt. Louis, Missouri Ms. Towerman has no relevant financial relationships to disclose. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ver todos los episodios